Ambu AS (OTCPK:AMBFF)
$ 19.9 -0.6 (-2.93%) Market Cap: 4.14 Bil Enterprise Value: 4.14 Bil PE Ratio: 123.69 PB Ratio: 5.18 GF Score: 97/100

Q3 2019 Ambu A/S Earnings Call Transcript

Aug 22, 2019 / 08:00AM GMT
Release Date Price: $14.88
Operator

Ladies and gentlemen, welcome to the Ambu Q3 interim report 2018-'19. (Operator Instructions) Today, I am pleased to present Nicolai Thomsen. Please begin your meeting.

Nicolai Thomsen;S;IR Manager
Ambu A

/-

Thank you. Good morning, everyone, and welcome to the conference call for Ambu's Q3 2018 and '19 report. My name is Nicolai, and I am from the Investor Relations team. With me today here at the Ambu head office in Copenhagen, I have our new CEO, Juan-José Gonzalez; and our CFO, Michael Højgaard.

As you probably noticed, we, late night, sent out a company announcement regarding a decision to go 100% direct in the U.S. This is something that we have worked on for some time, and we are happy to finally have reached an agreement with the U.S. pulmonary distributor.

The agenda for this conference call is that we will go through a presentation, where we also will provide a business and financial update from our Q3. And furthermore, we will provide further strategic insights of the decision to go 100% direct in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot